We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+11.66%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.77B
AUM Growth
-$63.7M
Cap. Flow
-$1.85M
Cap. Flow %
-0.1%
Top 10 Hldgs %
78.21%
Holding
42
New
–
Increased
2
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
MRKR icon
Marker Therapeutics
MRKR
+$1.96M
2
ORIC icon
Oric Pharmaceuticals
ORIC
+$606K

Top Sells

Rank Stock Value
1
CVRX icon
CVRx
CVRX
+$4.25M
2
MYND
Mynd.ai
MYND
+$165K
3
OKUR
OnKure Therapeutics
OKUR
+$15

Sector Composition

Rank Sector Weight
1 Healthcare 85.86%
2 Technology 7.19%
3 Consumer Staples 6.17%
4 Communication Services 0.58%
5 Industrials 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$287M 16.21%
3,745,262
– –
VRNA
2
DELISTED
Verona Pharma
VRNA
$259M 14.64%
5,584,753
– –
TEM
3
Tempus AI
TEM
$7.48B
$182M 10.26%
5,385,979
– –
RYTM icon
4
Rhythm Pharmaceuticals
RYTM
$7.31B
$163M 9.19%
2,909,956
– –
NN icon
5
NextNav
NN
$1.79B
$127M 7.19%
8,189,156
– –
COUR icon
6
Coursera
COUR
$1.77B
$109M 6.17%
12,867,769
– –
SVRA icon
7
Savara
SVRA
$1.08B
$75.1M 4.24%
24,471,264
– –
MBX
8
MBX Biosciences
MBX
$3.04B
$66.6M 3.76%
3,614,486
– –
CRSP icon
9
CRISPR Therapeutics
CRSP
$4.69B
$62.5M 3.53%
1,587,854
– –
GLUE icon
10
Monte Rosa Therapeutics
GLUE
$1.82B
$53.4M 3.01%
7,692,298
– –
TRVI icon
11
Trevi Therapeutics
TRVI
$2.57B
$48.8M 2.76%
11,370,376
– –
KRRO icon
12
Korro Bio
KRRO
$145M
$41.5M 2.34%
1,090,793
– –
AUPH icon
13
Aurinia Pharmaceuticals
AUPH
$1.95B
$35.6M 2.01%
3,969,834
– –
CVRX icon
14
CVRx
CVRX
$131M
$25.7M 1.45%
2,026,083
-344,459
-15% -$4.25M
ZBIO
15
Zenas BioPharma
ZBIO
$1.96B
$21.4M 1.21%
2,613,948
– –
NEUE
16
DELISTED
NeueHealth
NEUE
$20.2M 1.14%
2,726,917
– –
GOSS icon
17
Gossamer Bio
GOSS
$101M
$16.4M 0.92%
18,093,034
– –
CELC icon
18
Celcuity
CELC
$4.06B
$16.4M 0.92%
1,250,001
– –
PHAT icon
19
Phathom Pharmaceuticals
PHAT
$928M
$15.9M 0.9%
1,960,169
– –
CSBR icon
20
Champions Oncology
CSBR
$75.9M
$14.7M 0.83%
1,713,720
– –
ORIC icon
21
Oric Pharmaceuticals
ORIC
$1.17B
$12.6M 0.71%
1,566,081
+66,081
+4% +$606K
XFOR icon
22
X4 Pharmaceuticals
XFOR
$377M
$11M 0.62%
499,560
– –
BZFD icon
23
BuzzFeed
BZFD
$99M
$10.2M 0.58%
3,833,473
– –
RGLS
24
DELISTED
Regulus Therapeutics
RGLS
$10.2M 0.58%
6,467,802
– –
GERN icon
25
Geron
GERN
$898M
$9.83M 0.55%
2,776,409
– –
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q4 2024 Portfolio in Review

As of Q4 2024, NEA Management Company held 42 positions worth $1.77B, down 3.5% from $1.84B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 2.4%. NEA Management Company opened no new positions and exited 1, leaving the 42-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Staples.

  • NEA Management Company added most to Marker Therapeutics in Q4 2024, an estimated $1.96M increase.
  • NEA Management Company's biggest Q4 2024 reduction was CVRx, cutting an estimated $4.25M.
  • NEA Management Company fully exited Mynd.ai in Q4 2024, selling an estimated $165K.
  • NEA Management Company's ten largest holdings make up 78% of its $1.77B portfolio in Q4 2024.
  • NEA Management Company opened 0 new positions and closed 1 in Q4 2024.
  • NEA Management Company's portfolio value fell 3.5% quarter-over-quarter to $1.77B.

Based on NEA Management Company's 13F filing for Q4 2024, filed 14 Feb 2025.